Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Distler

Showing results (141-150 of 621) with videos related to

Pageof 63
Sort By:
Arthritis and Rheumatism|January 20, 2004
Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritisJörg H W Distler, Roland H Wenger, Max Gassmann, et al.
Annals of the Rheumatic Diseases|March 28, 2020
Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseMichael Hughes, Calvin Heal, Elise Siegert, et al.
Therapeutic Advances in Musculoskeletal Disease|October 20, 2025
Sex differences in systemic sclerosis: from pathogenesis to clinical manifestations and treatmentMelpomeni Toitou, Maria Iacovantuono, Gesa Sauer, et al.
Arthritis Research & Therapy|September 29, 2023
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL StartAdrian Ciurea, Oliver Distler, Kenneth Kwok, et al.
The Journal of Rheumatology|October 6, 2005
Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot studyFlorenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, et al.
Arthritis Research & Therapy|May 27, 2017
Tie2 as a novel key factor of microangiopathy in systemic sclerosisFalk Moritz, Janine Schniering, Jörg H W Distler, et al.
Annals of the Rheumatic Diseases|April 4, 2020
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILDCarina Mihai, Rucsandra Dobrota, Maria Schröder, et al.
Arthritis Research & Therapy|May 20, 2023
Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosisGabriella Nagy, Rucsandra Dobrota, Mike Oliver Becker, et al.
Arthritis and Rheumatism|January 1, 2009
Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosisAlfiya Akhmetshina, Paulius Venalis, Clara Dees, et al.
Methods (San Diego, Calif.)|November 28, 2024
Massively parallel flow-cytometry-based screening of hematopoietic lineage cell populations from up to 25 donors simultaneouslyJan Devan, Michaela Sandalova, Pamela Bitterli, et al.
Pageof 63

Showing results (141-150 of 621) with videos related to

Sort By:
Pageof 63
Arthritis and Rheumatism|January 20, 2004
Physiologic responses to hypoxia and implications for hypoxia-inducible factors in the pathogenesis of rheumatoid arthritisJörg H W Distler, Roland H Wenger, Max Gassmann, et al.
Annals of the Rheumatic Diseases|March 28, 2020
Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseMichael Hughes, Calvin Heal, Elise Siegert, et al.
Therapeutic Advances in Musculoskeletal Disease|October 20, 2025
Sex differences in systemic sclerosis: from pathogenesis to clinical manifestations and treatmentMelpomeni Toitou, Maria Iacovantuono, Gesa Sauer, et al.
Arthritis Research & Therapy|September 29, 2023
Joint-level responses to tofacitinib and methotrexate: a post hoc analysis of data from ORAL StartAdrian Ciurea, Oliver Distler, Kenneth Kwok, et al.
The Journal of Rheumatology|October 6, 2005
Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot studyFlorenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, et al.
Arthritis Research & Therapy|May 27, 2017
Tie2 as a novel key factor of microangiopathy in systemic sclerosisFalk Moritz, Janine Schniering, Jörg H W Distler, et al.
Annals of the Rheumatic Diseases|April 4, 2020
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILDCarina Mihai, Rucsandra Dobrota, Maria Schröder, et al.
Arthritis Research & Therapy|May 20, 2023
Characteristics of ScleroID highlighting musculoskeletal and internal organ implications in patients afflicted with systemic sclerosisGabriella Nagy, Rucsandra Dobrota, Mike Oliver Becker, et al.
Arthritis and Rheumatism|January 1, 2009
Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosisAlfiya Akhmetshina, Paulius Venalis, Clara Dees, et al.
Methods (San Diego, Calif.)|November 28, 2024
Massively parallel flow-cytometry-based screening of hematopoietic lineage cell populations from up to 25 donors simultaneouslyJan Devan, Michaela Sandalova, Pamela Bitterli, et al.
Pageof 63